ConductScience.org, home

Paper40909281

Mesenchymal stromal cells 2.0: thinking outside the box.

Mandl GA and 7 others. Front Immunol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Mesenchymal stromal cells 2.0: thinking outside the box. Papers, record 40909281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40909281

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mesenchymal stromal cells 2.0: thinking outside the box.
PubMed
Journal
Front Immunol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mandl GAGabrielle A
2Lahrichi MMalak
3Matar PPerla
4Abusarah JJamilah
5Farah RRoudy
6Bikorimana JPJean Pierre
7Cisse AAbba
8Rafei MMoutih

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mesenchymal Stem CellsMajor topic
Antigen-Presenting CellsMajor topic
Animals
Humans
Mesenchymal Stem Cell Transplantation
Neoplasms
Cancer Vaccines
Cell Differentiation
Cellular Reprogramming

Source PubMed

Download CSV of topics

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135563886The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes.Cells2022https://conductscience.org/library/papers/35563886PubMed
224872109Clinical use of dendritic cells for cancer therapy.Lancet Oncol2014https://conductscience.org/library/papers/24872109PubMed
316923606Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.Cytotherapy2006https://conductscience.org/library/papers/16923606PubMed
436394838
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
JAMA Oncol2023https://conductscience.org/library/papers/36394838PubMed
535492876Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.Cell Rep Med2022https://conductscience.org/library/papers/35492876PubMed
626907999Lipid peroxidation causes endosomal antigen release for cross-presentation.Sci Rep2016https://conductscience.org/library/papers/26907999PubMed
733923887Role of Proteasomes in Inflammation.J Clin Med2021https://conductscience.org/library/papers/33923887PubMed
85654088Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.Transplantation1968https://conductscience.org/library/papers/5654088PubMed
921412238Human immunology: a case for the ascent of non-furry immunology.Immunol Cell Biol2011https://conductscience.org/library/papers/21412238PubMed
1037254712Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37254712PubMed
1119654411Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.Blood2009https://conductscience.org/library/papers/19654411PubMed
1224566916Regulation of immune responses by extracellular vesicles.Nat Rev Immunol2014https://conductscience.org/library/papers/24566916PubMed
1330104634The immunoproteasome and thymoproteasome: functions, evolution and human disease.Nat Immunol2018https://conductscience.org/library/papers/30104634PubMed
1417540904Regulation of CD8+ T cell development by thymus-specific proteasomes.Science2007https://conductscience.org/library/papers/17540904PubMed
1515340416Cancer immunotherapy: moving beyond current vaccines.Nat Med2004https://conductscience.org/library/papers/15340416PubMed
1631730279Immune modulation by mesenchymal stem cells.Cell Prolif2020https://conductscience.org/library/papers/31730279PubMed
1740060894Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapy.iScience2025https://conductscience.org/library/papers/40060894PubMed
1835744930Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy.Molecules2022https://conductscience.org/library/papers/35744930PubMed
1916493000Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.Blood2006https://conductscience.org/library/papers/16493000PubMed
2015522656Part I: Vaccines for solid tumours.Lancet Oncol2004https://conductscience.org/library/papers/15522656PubMed

See all 93 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42840442Mesenchymal stromal cells and paracrine modulation of neuroplasticity in the central nervous system.EXCLI J2026https://conductscience.org/library/papers/42840442

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40909281

GET https://conductscience.org/api/papers/v1/40909281/references?page=2